Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Adjuvant immunotherapy in bronchogenic carcinoma.

H Takita, J Minowada, T Han

    Annals of the New York Academy of Sciences
    |January 1, 1976
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Periodontal tissue engineering by nano beta-tricalcium phosphate scaffold and fibroblast growth factor-2 in one-wall infrabony defects of dogs.

    Journal of periodontal research·2016
    Same author

    Placenta previa with early opening of the uterine isthmus is associated with high risk of bleeding during pregnancy, and massive haemorrhage during caesarean delivery.

    European journal of obstetrics, gynecology, and reproductive biology·2016
    Same author

    Influenza 2014-2015 among pregnant Japanese women: primiparous vs multiparous women.

    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2016
    Same author

    Prediction of early- and late-onset pregnancy-induced hypertension using placental volume on three-dimensional ultrasound and uterine artery Doppler.

    Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2014
    Same author

    Growth factor-loaded scaffolds for bone engineering.

    Journal of controlled release : official journal of the Controlled Release Society·2004
    Same author

    Carrier dependent cell differentiation of bone morphogenetic protein-2 induced osteogenesis and chondrogenesis during the early implantation stage in rats.

    Journal of biomedical materials research. Part A·2004
    Same journal

    Multiomics Profiling During Autoimmune Demyelination Highlights a Complex Regulatory Role for Ataxin-1 in B Cells.

    Annals of the New York Academy of Sciences·2026
    Same journal

    Global Trends in Light Pollution and Their Relationship With Socioeconomic Factors.

    Annals of the New York Academy of Sciences·2026
    Same journal

    Wired for Corruption: Inter-Brain Synchrony Encodes Bribery-Related Value Information and Predicts Bribery Agreement.

    Annals of the New York Academy of Sciences·2026
    Same journal

    LM-YOLO: A Lightweight Multi-Scale Enhanced Model for Forest Smoke Detection Using Unmanned Aerial Vehicles.

    Annals of the New York Academy of Sciences·2026
    Same journal

    Polyrhythm Perception and Production: A Scoping Review.

    Annals of the New York Academy of Sciences·2026
    Same journal

    DARTS-CNN-BiLSTM: Intelligent Fault Diagnosis for Computer Numerical Control Machine Tool Feed System.

    Annals of the New York Academy of Sciences·2026
    See all related articles

    Autologous tumor vaccine immunotherapy after surgery significantly improved survival for advanced lung cancer patients. Treated patients showed enhanced cellular immunity and tumor sensitization compared to controls.

    Area of Science:

    • Oncology
    • Immunology

    Background:

    • Advanced bronchogenic carcinoma presents a significant therapeutic challenge.
    • Radical surgical resection is a standard treatment, but recurrence rates remain high.

    Purpose of the Study:

    • To evaluate the efficacy of autologous tumor vaccine as an adjunct to radical surgery in patients with locally far advanced bronchogenic carcinoma.
    • To assess the impact of active immunotherapy on cellular immunity and patient survival.

    Main Methods:

    • Ten patients with advanced lung cancer received autologous tumor vaccine post-surgery.
    • A control group of nine patients underwent radical surgical resection alone.
    • Cellular immunity was assessed using the migration inhibition test.

    Main Results:

    Related Experiment Videos

    • The autologous tumor vaccine group demonstrated a median survival of 26 months, with 30% of patients alive.
    • The control group had a median survival of 6.5 months, with all patients deceased.
    • The migration inhibition test indicated sensitization of treated patients against their tumor, suggesting improved cellular immunity.

    Conclusions:

    • Active immunotherapy with autologous tumor vaccine following radical surgery may improve survival in advanced lung cancer.
    • Adjunctive immunotherapy appears to enhance postoperative cellular immunity and induce tumor-specific sensitization.